CVS
CVS Health CorpNYSE
Healthcare • Healthcare Plans
Factor tilt: Large-Cap Value
$83.85+3.10%
Close Nov 6, 2026
- Market cap
- $106.99B
- 1 month
- -4.5%
- 3 months
- -12.4%
- 1 year
- +6.7%
- 52-week range
- $70.08$110.60
- Dividend, last 12 mo
- $2.66 · 3.17% yield
- Last ex-date
- Oct 22, 2026 · $0.665
- Short interest
- 1.3% of float16.2M shares · settled Oct 15, 2026 · -1.7% since Sep 30, 2026 · FINRA
Fundamentals · trailing 12 months to Sep 30, 2026
- Revenue
- $420.61B
- Net income
- $11.05B
- Free cash flow
- $15.57B
- Book value
- $80.5B
- Total debt
- $75.3B
- P/E
- 9.7×
- Price / sales
- 0.3×
- Price / book
- 1.3×
- FCF yield
- +14.6%
- Net margin
- +2.6%
EODHD (TTM) · as of Nov 6, 2026
End-of-day close from stored market data, not a live quote.
About CVS Health Corp
CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care
Read more
management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail-order pharmacy, clinical services, disease management, medical spend management services, and pharmacy and other administrative services. It serves employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, CMS, plans offered on public health insurance exchanges, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, personal care products, and other general merchandise products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, retail specialty pharmacy stores, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.
- Website
- cvshealth.com
- Headquarters
- Woonsocket, RI, United States
- Employees
- 219,000
- Listed
- Dec 17, 1984
- Fiscal year ends
- December
Company profile from EODHD, stored Nov 7, 2026.
Quarterly results
The last 8 fiscal quarters as reported (EODHD). Year over year compares the same quarter a year earlier.
| Quarter | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Sep 2026filed Nov 4, 2026 | $108.4B | +5.4% | 13.7% | $3.6B | $2.2B |
| Jun 2026filed Aug 5, 2026 | $106.1B | +7.3% | 14.8% | $4.7B | $3.0B |
| Mar 2026filed May 6, 2026 | $100.4B | +6.2% | 15.6% | $4.7B | $2.9B |
| Dec 2025filed Feb 10, 2026 | $105.7B | +8.2% | 12.8% | $2.1B | $2.9B |
| Sep 2025filed Oct 29, 2025 | $102.9B | +7.8% | 13.4% | -$3.2B | -$4.0B |
| Jun 2025filed Jul 31, 2025 | $98.9B | +8.4% | 13.7% | $2.4B | $1.0B |
| Mar 2025filed May 1, 2025 | $94.6B | +7.0% | 15.2% | $3.4B | $1.8B |
| Dec 2024filed Feb 12, 2025 | $97.7B | +4.2% | 13.2% | $2.4B | $1.6B |
Fiscal years · last 6
| Fiscal year | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Dec 2025filed Feb 10, 2026 | $402.1B | +7.8% | 13.8% | $10.4B | $1.8B |
| Dec 2024filed Feb 12, 2025 | $372.8B | +4.2% | 13.8% | $8.5B | $4.6B |
| Dec 2023filed Feb 7, 2024 | $357.8B | +10.9% | 15.2% | $13.7B | $8.3B |
| Dec 2022filed Feb 8, 2023 | $322.5B | +10.4% | 16.9% | $8.0B | $4.3B |
| Dec 2021filed Feb 9, 2022 | $292.1B | +8.7% | 17.8% | $13.3B | $8.0B |
| Dec 2020filed Feb 16, 2021 | $268.7B | +4.6% | 18.3% | $13.9B | $7.2B |
Short-interest history
FINRA reports open short positions for a settlement date. The publication date is later. These are reported positions, with a separate date for each observation.
Compare the reported short exposure around the dates you bought, sold or watched CVS. A long position benefits from price rises; a short position benefits from falls. A change in these counts does not predict either move.
Settlement Oct 15, 2026
16,193,404 shares short
-276,747 shares (-1.7%) vs Sep 30, 2026
1.3% of the stored float. Published Oct 26, 2026.
Settlement Sep 30, 2026
16,470,151 shares short
+346,171 shares (+2.1%) vs Sep 15, 2026
1.3% of the stored float. Published Oct 9, 2026.
Settlement Sep 15, 2026
16,123,980 shares short
-1,990,671 shares (-11%) vs Aug 31, 2026
1.3% of the stored float. Published Sep 24, 2026.
Settlement Aug 31, 2026
18,114,651 shares short
+1,290,916 shares (+7.7%) vs Aug 14, 2026
1.4% of the stored float. Published Sep 10, 2026.
Settlement Aug 14, 2026
16,823,735 shares short
-1,852,735 shares (-9.9%) vs Jul 31, 2026
1.3% of the stored float. Published Aug 25, 2026.
Settlement Jul 31, 2026
18,676,470 shares short
-848,413 shares (-4.3%) vs Jul 15, 2026
1.5% of the stored float. Published Aug 11, 2026.
Change = this settlement’s shares short − the previous recorded settlement’s shares short; percentage change divides by that earlier count. A zero earlier count has no percentage change. Split-spanning counts are left uncompared. Float percentages use the stored settlement observation, not today’s float.
Source: stored FINRA equity short-interest records, up to six settlements from the last 240 days. FINRA data and reporting dates · How to read short interest
Dividends and stock splits
See the recorded cash amounts and dates behind CVS’s income, and the splits that change its share count. Dates below are stored event records, not confirmation of a payment to your account.
Cash-dividend records
USD 0.665 per share
Ex-dividend date: Oct 22, 2026
Recorded pay date: Nov 2, 2026 (past date)
Cash dividend · Polygon event record
USD 0.665 per share
Ex-dividend date: Jul 23, 2026
Recorded pay date: Aug 3, 2026 (past date)
Cash dividend · Polygon event record
USD 0.665 per share
Ex-dividend date: Apr 23, 2026
Recorded pay date: May 4, 2026 (past date)
Cash dividend · Polygon event record
USD 0.665 per share
Ex-dividend date: Jan 22, 2026
Recorded pay date: Feb 2, 2026 (past date)
Cash dividend · Polygon event record
USD 0.665 per share
Ex-dividend date: Oct 23, 2025
Recorded pay date: Nov 3, 2025 (past date)
Cash dividend · Polygon event record
USD 0.665 per share
Ex-dividend date: Jul 22, 2025
Recorded pay date: Aug 1, 2025 (past date)
Cash dividend · Polygon event record
Up to six Polygon cash-dividend events, including recorded ex-dates within the next 120 days. Amounts retain their recorded currency and decimal precision. Historical amounts are not restated to a common split basis, annualized, or converted to dollars.
For a long holding, compare the ex-date with when you held the shares and check the pay date against your broker’s cash history. Owning the stock today does not establish past entitlement. For a short holding, a dividend can create a payment obligation to the share lender.
Ex-dates and special dividend rules · Short-sale dividend obligations · Dividend data definitions
Split history
2 for 1 · forward split
Effective Jun 7, 2005
Each 1 pre-split share becomes 2 post-split shares.
Source: EODHD
2 for 1 · forward split
Effective Jun 16, 1998
Each 1 pre-split share becomes 2 post-split shares.
Source: EODHD
2 for 1 · forward split
Effective Mar 15, 1989
Each 1 pre-split share becomes 2 post-split shares.
Source: EODHD
2 for 1 · forward split
Effective May 3, 1983
Each 1 pre-split share becomes 2 post-split shares.
Source: EODHD
Up to six stored split dates through Nov 7, 2026. Equivalent vendor ratios are combined; conflicting ratios are left out. This history may be incomplete.
A split changes the share count and per-share price basis; it does not by itself add investment value. Put your holding’s earlier and later share counts on the same basis before comparing them. This applies to both long shares and shares owed on a short position.
How stock splits workPortfolio context
Sign in to see your position size
We’ll show you if CVS is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
Smart money context
Holder IQ: MEDIUM
274 smart-money holders: institutions with a high Holder IQ
Q2 2026, filed Oct 30, 2026
Smart-money 13F trend: accumulating (light)
Unlock crowding heatmapUnlock filer discoveryInsider context
Sentiment: neutral
Last trade: buy 1 days ago
Read the insider context evidence
What it means for you
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
What happened
Stored recent-activity label: neutral. This context label is separate from the scored insider signal read.
Why it can matter
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
How we got this
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Where the data comes from
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
Red flags: 3
Read the insider context evidence
What it means for you
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
What happened
Stored recent-activity label: neutral. This context label is separate from the scored insider signal read.
Why it can matter
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
How we got this
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Where the data comes from
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
Largest 13-F holders · Q2 2026
2,083 filers reported a long position in CVS for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
The top 10 hold
47%
of the 1.1B shares 13-F filers reported
Moves vs Q1 2026
6 added4 trimmed
Net shares held
+1.8%
across the 10 holders with a comparable Q1 2026 book
| Rank | Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $12.7B · 123.2M shares | 123.2M | -2.1% |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | $8.6B · 83.3M shares | 83.3M | +0.8% |
| 3 | Capital World Investors | $7.8B · 75M shares | 75M | -3% |
| 4 | STATE STREET CORP | $6.2B · 60.3M shares | 60.3M | +1.6% |
| 5 | DODGE & COX | $5.2B · 50M shares | 50M | -3.4% |
| 6 | WELLINGTON MANAGEMENT GROUP LLP | $3.5B · 33.8M shares | 33.8M | +49.8% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | $3.1B · 29.9M shares | 29.9M | +1.5% |
| 8 | FMR LLC | $3B · 28.9M shares | 28.9M | -7.3% |
| 9 | VANGUARD PORTFOLIO MANAGEMENT LLC | $2.8B · 26.6M shares | 26.6M | +2.5% |
| 10 | Capital Research Global Investors | $2.5B · 24.3M shares | 24.3M | +21.6% |
Sign in to see each holder’s Holder IQ, factor-adjusted Holder IQ and rank, and compare these holders with all scored filers. Available on every plan.
Sign in5% holder filings (13D / 13G)
Holders of more than 5% of CVS file with the SEC within days. A 13D holder may seek to influence the company; a 13G holder is passive. Each holder’s latest filing from the last three years.
| Filed | Holder | % of class |
|---|---|---|
| Aug 13, 2026 | DODGE & COX13G · passive · amended | 3.9%under 5% |
| Apr 29, 2026 | VANGUARD CAPITAL MANAGEMENT LLC13G · passive | 7.51% |
| Mar 26, 2026 | VANGUARD GROUP INC13G · passive · amended | 0%under 5% |
Get the Full Analysis for CVS
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.